Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Amato

Showing results (71-80 of 330) with videos related to

Pageof 33
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Aggressive multiple sclerosis (1): Towards a definition of the phenotypeEllen Iacobaeus, Georgina Arrambide, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 23, 2019
Correction to: Cognitive assessment in multiple sclerosis-an Italian consensusMaria Pia Amato, Vincenzo Brescia Morra, Monica Falautano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 17, 2018
Cognitive assessment in multiple sclerosis-an Italian consensusMaria Pia Amato, Vincenzo Brescia Morra, Monica Falautano, et al.
Journal of Neurology|May 3, 2002
The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in ItalyMaria Pia Amato, Mario A Battaglia, Domenico Caputo, et al.
Journal of Neurology|February 1, 2025
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinionMassimo Filippi, Maria Pia Amato, Carlo Avolio, et al.
Journal of Neurology|May 27, 2025
Personalized therapy in multiple sclerosis: an Italian Delphi consensusClaudio Gasperini, Diego Centonze, Antonella Conte, et al.
Neurology|October 16, 2015
Long-term assessment of no evidence of disease activity in relapsing-remitting MSNicola De Stefano, Maria Laura Stromillo, Antonio Giorgio, et al.
Developmental Neuropsychology|September 6, 2017
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple SclerosisNadine Akbar, Alessio Signori, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 2, 2022
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapiesAngelo Bellinvia, Maria Grazia Aprea, Emilio Portaccio, et al.
Journal of Neurology|September 22, 2022
Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Pageof 33

Showing results (71-80 of 330) with videos related to

Sort By:
Pageof 33
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Aggressive multiple sclerosis (1): Towards a definition of the phenotypeEllen Iacobaeus, Georgina Arrambide, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 23, 2019
Correction to: Cognitive assessment in multiple sclerosis-an Italian consensusMaria Pia Amato, Vincenzo Brescia Morra, Monica Falautano, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 17, 2018
Cognitive assessment in multiple sclerosis-an Italian consensusMaria Pia Amato, Vincenzo Brescia Morra, Monica Falautano, et al.
Journal of Neurology|May 3, 2002
The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in ItalyMaria Pia Amato, Mario A Battaglia, Domenico Caputo, et al.
Journal of Neurology|February 1, 2025
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinionMassimo Filippi, Maria Pia Amato, Carlo Avolio, et al.
Journal of Neurology|May 27, 2025
Personalized therapy in multiple sclerosis: an Italian Delphi consensusClaudio Gasperini, Diego Centonze, Antonella Conte, et al.
Neurology|October 16, 2015
Long-term assessment of no evidence of disease activity in relapsing-remitting MSNicola De Stefano, Maria Laura Stromillo, Antonio Giorgio, et al.
Developmental Neuropsychology|September 6, 2017
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple SclerosisNadine Akbar, Alessio Signori, Maria Pia Amato, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 2, 2022
Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapiesAngelo Bellinvia, Maria Grazia Aprea, Emilio Portaccio, et al.
Journal of Neurology|September 22, 2022
Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.
Pageof 33